SCHEDULE: Point72 Exits Position in Oric Pharmaceuticals

Point72 Asset Management and Steven A. Cohen have reported a 0% beneficial ownership stake in Oric Pharmaceuticals, Inc.

Summary

• Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have filed an amendment to their Schedule 13G.
• The filing confirms that the reporting persons now hold 0% of the common stock of Oric Pharmaceuticals, Inc.
• The event date for this change in ownership status is March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting a standard portfolio adjustment by an institutional investor.

Positives

• The filing provides full transparency regarding the complete divestment of the reporting entities' position in the issuer.

Negatives

• The exit of a major institutional investor like Point72 may be perceived as a lack of confidence in the short-to-medium term prospects of the issuer.

Risks

• Potential negative market sentiment resulting from the departure of a significant institutional shareholder.

Future Outlook

No future outlook provided as the reporting entities have fully exited their position.

Industry Context

StockSavvy.ai notes that institutional divestment in small-cap biotech firms is common as funds rebalance portfolios or reach investment horizons, though it often signals a shift in the stock's liquidity profile.

Comparison to Industry Standards

• The filing follows standard regulatory requirements for reporting the cessation of beneficial ownership above the 5% threshold.
• The exit is consistent with typical institutional trading patterns where large funds rotate out of clinical-stage biotech holdings.

Stakeholder Impact

• Shareholders may experience increased volatility due to the removal of a major institutional holder.

Next Steps

• None for the reporting persons as they no longer hold a position.

Key Dates

Keywords

Oric Pharmaceuticals, Point72, Divestment, Schedule 13G, Institutional Ownership, Steven A. Cohen